<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">122062</article-id><article-id pub-id-type="doi">10.23868/202004020</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association of TNF, MMP9, CYBA polymorphism with subclinical arterial wall changes and cardiovascular diseases risk factors</article-title><trans-title-group xml:lang="ru"><trans-title>Связь полиморфизма генов TNF, MMP9, CYBA с субклиническими изменениями артериальной стенки и факторами риска сердечно-сосудистых заболеваний</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akopyan</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Акопян</surname><given-names>А. А</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kirillova</surname><given-names>K. I</given-names></name><name xml:lang="ru"><surname>Кириллова</surname><given-names>К. И</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Strazhesko</surname><given-names>I. D</given-names></name><name xml:lang="ru"><surname>Стражеско</surname><given-names>И. Д</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Samokhodskaya</surname><given-names>L. M</given-names></name><name xml:lang="ru"><surname>Самоходская</surname><given-names>Л. М</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Leonov</surname><given-names>S. L</given-names></name><name xml:lang="ru"><surname>Леонов</surname><given-names>С. Л</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gelfand</surname><given-names>E. M</given-names></name><name xml:lang="ru"><surname>Гельфанд</surname><given-names>Е. М</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sorokina</surname><given-names>A. G</given-names></name><name xml:lang="ru"><surname>Сорокина</surname><given-names>А. Г</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Orlova</surname><given-names>I. A</given-names></name><name xml:lang="ru"><surname>Орлова</surname><given-names>Я. А</given-names></name></name-alternatives><email>a.alexandrova18@gmail.com</email><xref ref-type="aff" rid="aff7"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Медицинский научно-образовательный центр Московского государственного университета им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Clinical and Research Center of Gerontology N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">Медицинский научно-образовательный центр Московского государственного университета им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Российский геронтологический научно-клинический центр Российского национального исследовательского медицинского университета им. Н.И. Пирогова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Russian Clinical and Research Center of Gerontology N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">Алтайский государственный технический университет им. И.И. Ползунова</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Алтайский государственный технический университет им. И.И. Ползунова</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">I.I. Polzunov Altai State Technical University</institution></aff><aff><institution xml:lang="ru">Медицинский научно-образовательный центр Московского государственного университета им. М.В. Ломоносова</institution></aff></aff-alternatives><aff id="aff7"><institution>Medical Scientific and Educational Center of M.V. Lomonosov Moscow State University</institution></aff><pub-date date-type="pub" iso-8601-date="2020-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2020</year></pub-date><volume>15</volume><issue>2</issue><issue-title xml:lang="en">VOL 15, NO2 (2020)</issue-title><issue-title xml:lang="ru">ТОМ 15, №2 (2020)</issue-title><fpage>81</fpage><lpage>88</lpage><history><date date-type="received" iso-8601-date="2023-01-16"><day>16</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Эко-Вектор</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/122062">https://genescells.ru/2313-1829/article/view/122062</self-uri><abstract xml:lang="en"><p>Chronic inflammation and oxidative stress play key role in arterial wall changes and cardiovascular diseases. There is limited evidence on influence of genotypes, which are correlated with dironic inflammation and oxidative stress at arterial wall changes (pulse wave velocity, carotid artery intima-media thickness, endothelium-dependent vasodilation, presence of atherosclerotic plaques) and risk factors of cardiovascular diseases. We examined association of TNF-238G&gt;A polymorphism, MMP9 -1562C&gt;T polymorphism, CYBA c.214Т&gt;С polymorphism with arterial wall changes and risk factors of cardiovascular diseases in 160 healthy people of different ages. GG genotype of TNF -238G&gt;A polymorphism was associated with lower levels of aldosterone (p=0,021), higher levels of glycated haemoglobin (p=0,02) and insulin-like growth factor (p=0,032). СТ genotype of MMP9 -1562C&gt;T polymorphism was associated with most commonly found obesity (p=0,05). CC and TC genotypes of CYBA c.214Т&gt;С polymorphism were associated with shorter leucocyte telomere length (p=0,011). There wasn't found any association of TNF, MMP9, CYBA polymorphism with arterial wall changes. Association was found between TNF -238G&gt;A polymorphism and MMP9 -1562C&gt;T polymorphism with metabolic parameters, CYBA c.214Т&gt;С polymorphism with leucocyte telomere length.</p></abstract><trans-abstract xml:lang="ru"><p>Сердечно-сосудистые заболевания являются ведущей причиной смертности во всем мире. К факторам риска, приводящим к развитию сердечно-сосудистых заболеваний, относятся субклинические изменения артерий. Одну из ключевых ролей в развитии субклинических изменений артериальной стенки и сердечно-сосудистых заболеваний играет хроническое воспаление и окислительный стресс. Вклад полиморфных вариантов генов, связанных с усилением этих процессов с параметрами состояния артериальной стенки (скорость пульсовой волны, толщина комплекса интима-медиа, эндотелий-зависимая вазодилатация, наличие атеросклеротических бляшек) и факторами риска сердечно-сосудистых заболеваний, изучен недостаточно. Цель работы: с помощью межгруппового анализа и построения моделей множественной логистической регрессии исследовать связь полиморфизма -238G&gt;A гена TNF, -1562С&gt;Т гена MMP9 и с.214Т&gt;С гена CYBA с параметрами изменения артериальной стенки и факторами риска сердечно-сосудистых заболеваний у 160 относительно здоровых лиц разного возраста. У пациентов с генотипом GG полиморфизма -238G&gt;A гена TNF был отмечен более низкий уровень альдостерона (p=0,021), более высокие показатели гликированного гемоглобина (p=0,02) и инсулиноподобного фактора роста (p=0,032). Пациенты с генотипом СТ полиморфизма 1562С&gt;Т гена MMP9 чаще страдали ожирением (p=0,05). У пациентов с генотипом CC и ТС полиморфизма с.214Т&gt;С гена CYBA была обнаружена меньшая длина теломер лейкоцитов (p=0,011). Связи полиморфных вариантов генов TNF, MMP9 и CYBA с параметрами изменения артериальной стенки выявить не удалось. Была показана связь полиморфизма -238G&gt;A гена TNF и полиморфизма -1562С&gt;Т гена MMP9 с метаболическими параметрами, а также полиморфизма с.214Т&gt;С гена CYBA с длиной теломер лейкоцитов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>arterial stiffness</kwd><kwd>leucocyte telomere length</kwd><kwd>TNF polymorphism</kwd><kwd>MMP9 polymorphism</kwd><kwd>CYBA polymorphism</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериальная жесткость</kwd><kwd>длина теломе лейкоцитов</kwd><kwd>полиморфизм гена TNF</kwd><kwd>полиморфизм гена MMP9</kwd><kwd>полиморфизм гена CYBA</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cardiovascular diseases, (n. d.), https://www.who.int/westernpacific/health-topics/cardiovascular-diseases.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Стражеско И.Д., Акашева Д.У., Дудинская Е.Н. и др. Старение сосудов: основные признаки и механизмы. Кардиоваскулярная терапия и профилактика 2012; 11(4): 93-100.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Harvey A., Montezano A.C., Touyz R.M. Vascular biology of ageing - Implications in hypertension. J. Mol. Cell. Cardiol. 2015; 83: 112-21.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Strazhesko I.D., Tkacheva O.N., Akasheva D.U. et al. Growth hormone, insulin-like growth factor-1, insulin resistance, and leukocyte telomere length as determinants of arterial aging in subjects free of cardiovascular diseases. Front. Genet. 2017; 15(8): 198.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sirbu A., Nicolae H., Martin S. et al. IGF-1 and insulin resistance are major determinants of common carotid artery thickness in morbidly obese young patients. Angiology 2016; 67(3): 259-65.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>McDonnell B.J., Yasmin, Butcher L. et al. The age-dependent association between aortic pulse wave velocity and telomere length. J. Physiol. 2017; 595(5): 1627-35.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Pulido-Gomez K., Hernadez-Diaz Y., Tovilla-Zarate C.A. et al. Association of G308A and G238A Polymorphisms of the TNF-α Gene with Risk of Coronary Heart Disease: Systematic Review and Meta-analysis. Arch. Med. Res. 2016; 47(7): 557-72.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Morgan A.R., Zhang B., Tapper W. et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J. Mol. Med. (Berl.) 2003; 81(5): 321-6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Xu Q., Yuan F., Shen X. et al. Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: a meta-analysis. PLos One 2014; 9(1): e84251.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kumar P., Misra S., Kumar A. et al. Association between tumor necrosis factor-а (-238G/A and -308G/A) gene polymorphisms and risk of ischemic stroke: a meta-analysis. Pulse (Basel) 2015; 3: 217-28.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Buraczynska K., Kurzepa J., Ksiazek A. et al. Matrix metalloproteinase-9 (MMP-9) gene polymorphism in stroke patients. Neuromolecular Med. 2015; 17: 385-90.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yang W., Lu J., Yang L. et al. Association of matrix metalloproteinase-9 gene -1562C/T polymorphism with essential hypertension: a systematic review and meta-analysis article. Iran J. Public Health 2015; 44(11): 1445-52.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10): e47.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kamata H., Honda S.I., Maeda S. et al. Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120(5): 649-61.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Vlachopoulos C., Gravos A., Georgiopoulos G. et al. The effect of TNF-a antagonists on aortic stiffness and wave reflections: a metaanalysis. Clin. Rheumatol. 2018; 37(2): 515-26.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Tao Y., Xiong Y., Wang H. et al. APOC3 induces endothelial dysfunction through TNF-а and JAM-1. Lipids in Health and Disease 2016; 15(1): 153.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Huang M.J., Wei R.B., Zhao J. et al. Albuminuria and endothelial dysfunction in patients with non-diabetic chronic kidney disease. Med. Sci. Monit. 2017; 23: 4447-53.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Liu S., Hempe J.M., McCarter R.J. et al. Association between inflammation and biological variation in hemoglobin A1c in U.S. Nondiabetic Adults. J. Clin. Endocrinol. Metab. 2015; 100(6): 2364-71.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Cheng Y., An B., Jiang M. et al. Association of tumor necrosis factoralpha polymorphisms and risk of coronary artery disease in patients with non-alcoholic fatty liver disease. Hepat. Mon. 2015; 15(3): e26818.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wu J., Zhang X., Wang J. et al. Gene polymorphisms and circulating levels of the TNF-alpha are associated with ischemic stroke: a meta-analysis based on 19,873 individuals. International Immunopharmacology 2019; 75: 105827.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Hou L., Huang J., Lu X. et al. Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: Interaction with cigarette smoking. Thrombosis Research 2009; 123(6): 822-6.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Yabluchanskiy A., Ma Y., Iyer R.P. et al. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda) 2013; 28(6): 391-403.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mehde A.A., Mehdi W.A., Yusof F. et al. Association of MMP-9 gene polymorphisms with nephrolithiasis patients. J Clin. Lab. Analys. 2018; 32(1): e22173.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Manna P., Jain S.K. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab. Syndr. Relat. Disord. 2015; 13(10): 423-44.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Meschiari C.A., Ero O.K., Pan H. et al. The impact of aging on cardiac extracellular matrix. GeroScience 2017; 39(1): 7-18.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Luizon M.R., Belo V.A., Fernandes K.S. et al. Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects. Mol. Biol. Rep. 2016; 43(6): 463-71.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Rodriguez-Pérez J.M., Vargas-Alarcôn G., Posadas-Sanchez R. et al. rs3918242 MMP9 gene polymorphism is associated with myocardial infarction in Mexican patients. Genet. Mol. Res. 2016; 15(1): 15017776.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zhang M.M., Chang X.W., Hao X.Q. et al. Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis. Oncotarget 2018; 9(10): 9468-79.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Стражеско И.Д., Ткачева О.Н., Акашева Д.У. и др. Взаимосвязь компонентов метаболического синдрома с параметрами клеточного и сосудистого старения. Российский кардиологический журнал 2014; 6: 30-4.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Tian R., Zhang L.N., Zhang T.T. et al. Association between oxidative stress and peripheral leukocyte telomere length in patients with premature coronary artery disease. Med. Sci. Monit. 2017; 23: 4382-90.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Fyhrquist F., Saijonmaa O., Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat. Rev. Cardiol. 2013; 10(5): 274-83.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Papapetrou A., Moris D., Patelis N. et al. Oxidative stress and total antioxidant status during internal carotid artery clamping with or without shunting: An experimental pilot study. Med. Sci. Monit. Basic Res. 2014; 21: 200-5.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Ji Y., Ge J., Zhu Z. et al. Relationship between C242T polymorphism and arterial stiffness in an apparently healthy population. J. Hum. Hypertens. 2016; 30(8): 488-92.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cheng H.M., Park S., Huang Q. et al. Characteristics on the Management of Hypertension in Asia - Morning Hypertension Discussion Group (COME Asia MHDG), Vascular aging and hypertension: Implications for the clinical application of central blood pressure. Int. J. Cardiol. 2017; 230: 209-13.</mixed-citation></ref></ref-list></back></article>
